Applications are now being accepted for the 2020-2021 cycle of ASCO’s Health Policy Leadership Development program. The Health Policy Leadership Development Program is a one-year program that gives ASCO members the opportunity to develop expertise in health policy, advocacy, and grassroots activity while learning valuable leadership skills.
Oncologists have an important role to play in shaping the policies that affect patients with cancer and the entire cancer care delivery system. Changes in political priorities and the healthcare landscape have expanded the range of policy issues ASCO addresses and has prompted the need for strong volunteer leaders who understand and can effectively communicate ASCO’s policy priorities.
Potential applicants to the Health Policy Leadership Development Program can expect the following if selected:
- Practical experience working with ASCO Policy and Advocacy staff and policy counsel in crafting policy positions and statements;
- Small-group teaching sessions delivered by an executive leadership coach, ASCO professional staff, and qualified volunteers;
- Training in communication, leadership, and advocacy;
- A mentored project that advances an ASCO policy initiative.
Participants in the program are also full members of the ASCO Leadership Development Program, allowing them to focus on building expertise in health policy while also gaining valuable leadership skills and mentorship from ASCO leaders. After successful completion of the program, participants will be appointed to serve on an ASCO committee.
The Health Policy Leadership Development Program is open to all ASCO members in the United States who have completed their final subspecialty training between 2010 and 2015. Participants in the program will travel to ASCO approximately one week per month, with ASCO covering travel costs and living expenses.
The deadline to apply to the Health Policy Leadership Development Program is September 25, 2019. Learn more about the program and apply now.
ASCO's Health Policy Leadership Development Program is supported by the Mission Endowment of ASCO’s Conquer Cancer Foundation